Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment

por Takahashi, Maika, Saito, Kaori, Ai, Tomohiko, Nojiri, Shuko, Khasawneh, Abdullah, Paran, Faith Jessica, Horiuchi, Yuki, Takei, Satomi, Yamamoto, Takamasa, Wakita, Mitsuru, Hiki, Makoto, Miida, Takashi, Naito, Toshio, Takahashi, Kazuhisa, Tabe, Yoko
Publicado 2023

Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination

por Takahashi, Toshihiro, Ai, Tomohiko, Saito, Kaori, Nojiri, Shuko, Takahashi, Maika, Igawa, Gene, Yamamoto, Takamasa, Khasawneh, Abdullah, Paran, Faith Jessica, Takei, Satomi, Horiuchi, Yuki, Kanno, Takayuki, Tobiume, Minoru, Hiki, Makoto, Wakita, Mitsuru, Miida, Takashi, Okuzawa, Atsushi, Suzuki, Tadaki, Takahashi, Kazuhisa, Naito, Toshio, Tabe, Yoko
Publicado 2023

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies

por Takahashi, Maika, Ai, Tomohiko, Sinozuka, Konomi, Baba, Yuna, Igawa, Gene, Nojiri, Shuko, Yamamoto, Takamasa, Yuri, Maiko, Takei, Satomi, Saito, Kaori, Horiuchi, Yuki, Kanno, Takayuki, Tobiume, Minoru, Khasawneh, Abdullah, Paran, Faith Jessica, Hiki, Makoto, Wakita, Mitsuru, Miida, Takashi, Suzuki, Tadaki, Okuzawa, Atsushi, Takahashi, Kazuhisa, Naito, Toshio, Tabe, Yoko
Publicado 2022